- Home
- FICO vs CINGW Comparison
FICO vs CINGW Comparison
Compare FICO & CINGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FICO
- CINGW
- Stock Information
- Founded
- FICO 1956
- CINGW N/A
- Country
- FICO United States
- CINGW United States
- Employees
- FICO N/A
- CINGW 13
- Industry
- FICO Business Services
- CINGW Biotechnology: Pharmaceutical Preparations
- Sector
- FICO Consumer Discretionary
- CINGW Health Care
- Exchange
- FICO Nasdaq
- CINGW Nasdaq
- Market Cap
- FICO 46.1B
- CINGW N/A
- IPO Year
- FICO 1987
- CINGW 2021
- Fundamental
- Price
- FICO $1,953.20
- CINGW $0.04
- Analyst Decision
- FICO Buy
- CINGW
- Analyst Count
- FICO 11
- CINGW 0
- Target Price
- FICO $2,242.27
- CINGW N/A
- AVG Volume (30 Days)
- FICO 192.2K
- CINGW N/A
- Earning Date
- FICO 04-29-2025
- CINGW N/A
- Dividend Yield
- FICO N/A
- CINGW N/A
- EPS Growth
- FICO 21.78
- CINGW N/A
- EPS
- FICO 21.79
- CINGW N/A
- Revenue
- FICO $1,775,435,000.00
- CINGW N/A
- Revenue This Year
- FICO $17.79
- CINGW N/A
- Revenue Next Year
- FICO $15.57
- CINGW N/A
- P/E Ratio
- FICO $89.65
- CINGW N/A
- Revenue Growth
- FICO 14.49
- CINGW N/A
- 52 Week Low
- FICO $1,131.03
- CINGW N/A
- 52 Week High
- FICO $2,402.52
- CINGW N/A
- Technical
- Relative Strength Index (RSI)
- FICO 58.07
- CINGW N/A
- Support Level
- FICO $1,885.62
- CINGW N/A
- Resistance Level
- FICO $1,956.75
- CINGW N/A
- Average True Range (ATR)
- FICO 66.93
- CINGW 0.00
- MACD
- FICO 10.29
- CINGW 0.00
- Stochastic Oscillator
- FICO 91.91
- CINGW 0.00
About FICO Fair Isaac Corproation
Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's credit scores business accounts for most of the firm's profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.
About CINGW Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.